Figure 6From: A Systems Biology Strategy for Predicting Similarities and Differences of Drug Effects: Evidence for Drug-specific Modulation of Inflammation in AtherosclerosisEffect of fenofibrate and LXR agonist T0901317 on inflammatory networks and pathways. Pathways and transcription factors modulated by A, fenofibrate (FF) and B, LXR agonist T0901317 (T09) under HC conditions essentially as described in Figure 5.Back to article page